Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.23.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2023
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands):

 

 

March 31, 2023

 

 

December 31, 2022

 

External research and preclinical development

 

$

9,410

 

 

$

8,219

 

Employee compensation and benefits

 

 

2,998

 

 

 

8,529

 

Professional fees

 

 

1,184

 

 

 

1,164

 

Facilities and other

 

 

157

 

 

 

54

 

Accrued expenses

 

$

13,749

 

 

$

17,966